The international need for antimicrobial drugs as commodities is steadily growing. This pattern can be linked to a number of factors, like the rapid spread of antibiotic-resistant bacteria and the burgeoning population in third-world countries. The medicine industry is reacting to this demand by boosting production and researching new medicines. H